Target Group Inc. (CBDY)
OTCMKTS · Delayed Price · Currency is USD
0.0018
-0.0001 (-5.26%)
At close: Dec 3, 2025
Target Group Market Cap
Target Group has a market cap or net worth of $1.11 million as of December 5, 2025. Its market cap has decreased by -42.31% in one year.
Market Cap
1.11M
Enterprise Value
3.96M
Revenue
5.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 28, 2015, Target Group's market cap has decreased from 8.63M to 1.11M, a decrease of -87.12%. That is a compound annual growth rate of -18.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 1.11M | 28.57% |
| Dec 31, 2024 | 863.84K | -23.91% |
| Dec 29, 2023 | 1.14M | -54.00% |
| Dec 30, 2022 | 2.47M | -54.55% |
| Dec 31, 2021 | 5.43M | -32.35% |
| Dec 31, 2020 | 8.03M | -28.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 561.91M |
| Glass House Brands | 513.14M |
| CytoDyn | 403.93M |
| American Oncology Network | 365.47M |
| Northwest Biotherapeutics | 363.73M |
| Silence Therapeutics | 328.75M |
| Nika Pharmaceuticals | 259.91M |